Skip to main content
Loading

The hidden catalyst for AI breakthroughs in drug discovery

17 Sep 2025
Data Quality
  • How do we define acceptable data quality for AI in drug discovery when perfect data is unrealistic?
  • Should we prioritize collecting more diverse datasets or focus on rigorous curation of smaller, high-quality datasets?
  • What are the promising AI-assisted approaches for detecting errors, normalizing data, and augmenting incomplete datasets?
  • How can the industry agree on common data formats, ontologies, and metadata standards without stifling innovation?
Industry Expert
Salima Ismayilova, Director Business Development - US West - Collaborative Drug Discovery (CDD)

CDD Vault